NIH-funded research R01 grant

Anemia after severe burns

Official title: Inflammatory Mechanisms in Post Burn Anemia of Critical Illness

Funded at University of Cincinnati · NIH-11262815 · Data updated 2026-11-12

Researchers are looking at how inflammation from severe burns causes anemia to find ways to reduce blood transfusions for burn patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJanuary 1, 2022
Project endDecember 31, 2026
Funding year2026
Award (this year)$393,572
NIH project number5R01HL155579-05
Project IDNIH-11262815 on NIH RePORTER

Who could benefit from this research

Could help

Patients with significant burn injuries or critically ill burn patients who are experiencing anemia and are treated in or referred to a burn unit or ICU.

Less likely to help

People with anemia from chronic non-inflammatory causes or conditions unrelated to acute burn/critical illness are unlikely to benefit from this research.

What this research studies

As a burn patient, this project looks at how inflammation in the burn wound makes it hard to make and keep red blood cells by blocking normal erythropoietin signals and limiting iron. The team will measure inflammatory signals such as G‑CSF and IL‑6 and study how those signals affect erythropoiesis and iron handling. They will use patient-derived samples and laboratory models to pinpoint which inflammatory steps can be targeted. The overall aim is to identify treatments that lower transfusion needs in burn unit and ICU patients.

Why it matters

Potential benefit: If successful, this could reduce the need for blood transfusions by restoring red blood cell production after severe burns.

How similar studies have gone: Prior work shows erythropoietin and iron often fail in this setting and links IL‑6 and other inflammatory molecules to anemia, but directly targeting these pathways in burn-related anemia is still relatively novel.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Gardner, Jason — University of Cincinnati
  • Study coordinator: Gardner, Jason

Related research

Other NIH-funded projects on the same topics.

  • Understanding how inflammation causes anemia in burn patients

    This study is looking at why people with severe burns often have anemia, especially how inflammation might be making it harder for their bodies to produce red blood cells, and it aims to find new ways to help reduce the need for blood transfusions during their recovery.

    NIH research University of Cincinnati · Cincinnati, United States · NIH-11010769

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

  • Hydroxyurea for Children with Sickle Cell Disease in Africa

    A safe and feasible use of hydroxyurea for young children with sickle cell disease in several African countries to reduce illness and improve daily life.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606509

  • Glucocorticoids and critical illness outcomes in ICU patients

    A researcher team at Columbia University will study how glucocorticoids affect short- and long-term outcomes for people who survive critical illness, including mental health and recovery aspects.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11580346

  • Stem cell problems in Diamond-Blackfan anemia

    This project looks at why blood-forming stem cells don't work well in Diamond-Blackfan anemia by studying the common RPS19 gene change and its effects on TP53 and PRC2 pathways.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11481769

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.